All News

The FDA approval of solifenacin succinate marks the first for the treatment of young pediatric patients with NDO.

New York Governor Andrew Cuomo announced last week that New York will launch a COVID-19 testing pilot program with a goal of conducting 7000 tests per week.

A study released today demonstrated that tocilizumab has been shown to significantly improve survival outcomes for patients with COVID-19.

Many patients are under the false assumption that there are no risks or potential drug interactions posed by taking OTC medications.

Artesunate for injection is on the World Health Organization Model List of Essential Medicines.

Pharmacists can leverage EHR to compare and contrast medication lists, link medications to patient problems, and evaluate effectiveness and adverse drug events.

Today, we’re celebrating Bailey Dodd, PharmD, and Macie Sobers, PharmD, both pharmacists at Walgreens in Birmingham, Alabama.

The therapy is approved for patients with squamous or non-squamous disease and regardless of programmed death-ligand 1 (PD-L1) expression.

Elizabeth Skoy, PharmD, and Amy Werremeyer, PharmD, BCPP, associate professors at the North Dakota State University School of Pharmacy, discuss what they feel is the value of the pharmacist.

Pharmacists are routinely putting others ahead of themselves and may not be sure how to find time for self-care.

The FDA recently announced its approval of a vaginal gel that acts as a method of contraception for women. It is the first non-hormonal, vaginal pH regulator contraceptive to be approved by the FDA.

The Nontraditional Pharmacist podcast presents a discussion about pharmacists practicing integrative medicine and touch on the business implications of integrative medicine in the future.

The work and expertise of a drug utilization pharmacist should be empowered and integrated earlier into a recall process.

Today, we’re thanking Dustin Linn, PharmD, RPh, BCCCP, and Trent Towne, PharmD, RPh, BCPS (AQID), for their work treating patients with COVID-19.

Migraines are a common condition, affecting about 38 million people in the United States and about 10% of people worldwide.

As we consider the implications of the COVID-19 pandemic and the release of remdesivir, ICER’s expedited evaluation raises some questions related to value-based pricing evaluations.

Although most children admitted to pediatric ICUs for COVID-19 had underlying conditions, children, teens, and young adults are at a greater risk for severe complications than researchers had previously believed.

Oncology teams may struggle to balance effectively caring for patients with lung cancer while avoiding exposure risks and safety amid the COVID-19 pandemic.

Live remote proctoring offers a safe, secure, socially distanced testing experience.

Why was a customer prescribed an allergy medication when she was expecting a pain pill?

As we age, scientists can measure declining levels of adenosine triphosphate and other biochemicals in our bodies, but research is looking at how aging and diseases can be reversed.

Today, we’re celebrating the work of Hussain Abdulwahab, MPharm, a pharmacist in Sweden.

Nutrients should come from food, but when that is not enough, vitamin supplementation is an option.

Elizabeth Skoy, PharmD and Amy Werremeyer, PharmD, BCPP, discuss what patients wish their pharmacists knew about mental health.

Because of continuing social distancing policies and stay-at-home orders, many families have been unable to grieve their family members at funerals or other family gatherings.

The National Home Infusion Foundation (NHIF) announced yesterday that the winner of the 2020 Outstanding Abstract Achievement Award is Rachel Dellevar, PharmD.

Officials with the FDA have approved apomorphine hydrochloride sublingual film (APL-130277) for the acute, intermittent treatment of OFF episodes in patients with Parkinson disease.

Which English king started the first recognized pharmacy organization in the western world?

Top news of the week from Pharmacy Times® surrounding the novel coronavirus.

According to the study authors, patients with MS who underwent the 4-week mindfulness training not only showed greater improvement in processing speed and regulating negative emotions than those who did not participate in any training, but they also improved compared with those who tried adaptive cognitive training (ACT).